Northern Trust Corp Surmodics Inc Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Surmodics Inc stock. As of the latest transaction made, Northern Trust Corp holds 129,337 shares of SRDX stock, worth $4.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
129,337
Previous 126,540 2.21%
Holding current value
$4.93 Million
Previous $5.32 Million 5.72%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$38.47 - $42.24 $107,600 - $118,145
2,797 Added 2.21%
129,337 $5.02 Million
Q2 2024

Aug 14, 2024
SELL
$25.39 - $42.1 $159,906 - $265,145
-6,298 Reduced 4.74%
126,540 $5.32 Million
Q1 2024

May 14, 2024
SELL
$27.44 - $35.56 $120,351 - $155,966
-4,386 Reduced 3.2%
132,838 $3.9 Million
Q4 2023

Feb 13, 2024
BUY
$28.47 - $38.49 $6,861 - $9,276
241 Added 0.18%
137,224 $4.99 Million
Q3 2023

Nov 13, 2023
BUY
$28.28 - $38.36 $53,958 - $73,190
1,908 Added 1.41%
136,983 $4.4 Million
Q2 2023

Aug 11, 2023
SELL
$17.67 - $31.31 $792,093 - $1.4 Million
-44,827 Reduced 24.92%
135,075 $4.23 Million
Q1 2023

May 15, 2023
BUY
$17.13 - $38.52 $187,299 - $421,177
10,934 Added 6.47%
179,902 $4.1 Million
Q4 2022

Feb 13, 2023
BUY
$29.44 - $37.31 $238,051 - $301,688
8,086 Added 5.03%
168,968 $5.77 Million
Q3 2022

Nov 14, 2022
SELL
$28.84 - $38.92 $8,392 - $11,325
-291 Reduced 0.18%
160,882 $4.89 Million
Q2 2022

Aug 12, 2022
SELL
$33.25 - $45.11 $90,174 - $122,338
-2,712 Reduced 1.65%
161,173 $6 Million
Q1 2022

May 13, 2022
SELL
$40.68 - $49.72 $278,739 - $340,681
-6,852 Reduced 4.01%
163,885 $7.43 Million
Q4 2021

Feb 08, 2022
SELL
$43.21 - $57.6 $219,722 - $292,896
-5,085 Reduced 2.89%
170,737 $8.22 Million
Q3 2021

Nov 15, 2021
BUY
$52.8 - $60.32 $22,492 - $25,696
426 Added 0.24%
175,822 $9.78 Million
Q2 2021

Aug 13, 2021
BUY
$51.29 - $59.15 $57,803 - $66,662
1,127 Added 0.65%
175,396 $9.52 Million
Q1 2021

May 12, 2021
SELL
$42.18 - $56.07 $442,847 - $588,678
-10,499 Reduced 5.68%
174,269 $9.77 Million
Q4 2020

Feb 11, 2021
SELL
$35.18 - $43.52 $214,738 - $265,646
-6,104 Reduced 3.2%
184,768 $8.04 Million
Q3 2020

Nov 16, 2020
SELL
$37.98 - $48.72 $323,399 - $414,850
-8,515 Reduced 4.27%
190,872 $7.43 Million
Q2 2020

Aug 14, 2020
BUY
$31.07 - $44.74 $222,585 - $320,517
7,164 Added 3.73%
199,387 $8.62 Million
Q1 2020

May 14, 2020
BUY
$22.46 - $42.24 $39,686 - $74,638
1,767 Added 0.93%
192,223 $6.41 Million
Q4 2019

Feb 14, 2020
SELL
$39.01 - $47.51 $216,115 - $263,205
-5,540 Reduced 2.83%
190,456 $7.89 Million
Q3 2019

Nov 13, 2019
BUY
$38.66 - $47.41 $173,815 - $213,155
4,496 Added 2.35%
195,996 $8.97 Million
Q2 2019

Aug 13, 2019
BUY
$38.23 - $47.43 $25,652 - $31,825
671 Added 0.35%
191,500 $8.27 Million
Q1 2019

May 13, 2019
BUY
$41.26 - $58.35 $105,790 - $149,609
2,564 Added 1.36%
190,829 $8.3 Million
Q4 2018

Feb 12, 2019
SELL
$44.93 - $73.38 $69,776 - $113,959
-1,553 Reduced 0.82%
188,265 $8.9 Million
Q3 2018

Nov 14, 2018
BUY
$56.85 - $80.35 $180,271 - $254,789
3,171 Added 1.7%
189,818 $14.2 Million
Q2 2018

Sep 18, 2018
SELL
$35.85 - $57.05 $30,114 - $47,922
-840 Reduced 0.45%
186,647 $10.3 Million
Q2 2018

Aug 14, 2018
BUY
$35.85 - $57.05 $106,259 - $169,096
2,964 Added 1.61%
187,487 $10.4 Million
Q1 2018

May 09, 2018
BUY
$27.0 - $38.5 $86,481 - $123,315
3,203 Added 1.77%
184,523 $7.02 Million
Q4 2017

Feb 14, 2018
SELL
$28.0 - $33.2 $100,380 - $119,022
-3,585 Reduced 1.94%
181,320 $5.08 Million
Q3 2017

Nov 13, 2017
BUY
$24.5 - $31.1 $4.53 Million - $5.75 Million
184,905
184,905 $5.73 Million

Others Institutions Holding SRDX

# of Institutions
126
Shares Held
12M
Call Options Held
1.4K
Put Options Held
8.6K
View Full List

About SURMODICS INC

SRDX Quotes by TradingView
  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $533M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email